China Longevity (1863) Announces Ongoing Trading Suspension and Regulatory Developments

Bulletin Express

Oct 31, 2025

China Longevity Group Company Limited (1863) announced that its production, operation, and finances remain in stable condition. The company intends to continue focusing on research and development of new materials and products.

According to the latest update, the company’s shares have been suspended from trading on the Stock Exchange since 14 February 2013. The Stock Exchange has not issued any new delisting notice to date, and previous communication indicated that it would refrain from exercising its right to delist until further notice.

The Securities and Futures Commission (SFC) remains engaged in a regulatory review related to a Show Cause Letter issued in November 2014. A Resumption Application was submitted in December 2019, and, following additional meetings in 2020 and 2021, the Commission’s Board has yet to reach a final decision. The review remains ongoing, with the Commission potentially seeking further information.

China Longevity notes that trading in its shares will remain suspended until further notice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1129157356"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129157356\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129157356?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 21:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129157356","market":"us","top_or_hot":-1,"title":"China Longevity (1863) Announces Ongoing Trading Suspension and Regulatory Developments","media":"Bulletin Express","content":"<p>China Longevity Group Company Limited (1863) announced that its production, operation, and finances remain in stable condition. The company intends to continue focusing on research and development of new materials and products.</p>\n<p>According to the latest update, the company’s shares have been suspended from trading on the Stock Exchange since 14 February 2013. The Stock Exchange has not issued any new delisting notice to date, and previous communication indicated that it would refrain from exercising its right to delist until further notice.</p>\n<p>The Securities and Futures Commission (SFC) remains engaged in a regulatory review related to a Show Cause Letter issued in November 2014. A Resumption Application was submitted in December 2019, and, following additional meetings in 2020 and 2021, the Commission’s Board has yet to reach a final decision. The review remains ongoing, with the Commission potentially seeking further information.</p>\n<p>China Longevity notes that trading in its shares will remain suspended until further notice.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Longevity (1863) Announces Ongoing Trading Suspension and Regulatory Developments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Longevity (1863) Announces Ongoing Trading Suspension and Regulatory Developments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-31 21:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Longevity Group Company Limited (1863) announced that its production, operation, and finances remain in stable condition. The company intends to continue focusing on research and development of new materials and products.</p>\n<p>According to the latest update, the company’s shares have been suspended from trading on the Stock Exchange since 14 February 2013. The Stock Exchange has not issued any new delisting notice to date, and previous communication indicated that it would refrain from exercising its right to delist until further notice.</p>\n<p>The Securities and Futures Commission (SFC) remains engaged in a regulatory review related to a Show Cause Letter issued in November 2014. A Resumption Application was submitted in December 2019, and, following additional meetings in 2020 and 2021, the Commission’s Board has yet to reach a final decision. The review remains ongoing, with the Commission potentially seeking further information.</p>\n<p>China Longevity notes that trading in its shares will remain suspended until further notice.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01863","symbol_name":"中国龙天集团","start_time":0,"source_url":"","article_id":"1129157356","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129157356","pubTimestamp":1761918401,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Longevity Group Company Limited (1863) announced that its production, operation, and finances remain in stable condition. The company intends to continue focusing on research and development of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01863":"中国龙天集团"},"translate_title":"中国长寿(1863)公布持续停牌及监管动态","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01863":1},"content_text":"China Longevity Group Company Limited (1863) announced that its production, operation, and finances remain in stable condition. The company intends to continue focusing on research and development of new materials and products.\nAccording to the latest update, the company’s shares have been suspended from trading on the Stock Exchange since 14 February 2013. The Stock Exchange has not issued any new delisting notice to date, and previous communication indicated that it would refrain from exercising its right to delist until further notice.\nThe Securities and Futures Commission (SFC) remains engaged in a regulatory review related to a Show Cause Letter issued in November 2014. A Resumption Application was submitted in December 2019, and, following additional meetings in 2020 and 2021, the Commission’s Board has yet to reach a final decision. The review remains ongoing, with the Commission potentially seeking further information.\nChina Longevity notes that trading in its shares will remain suspended until further notice.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}